Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study

Shiwei Liu, Yichong Li, Xinying Zeng, Haidong Wang, Peng Yin, Lijun Wang, Yunning Liu, Jiangmei Liu, Jinlei Qi, Sha Ran, Shiya Yang, Maigeng Zhou, Shiwei Liu, Yichong Li, Xinying Zeng, Haidong Wang, Peng Yin, Lijun Wang, Yunning Liu, Jiangmei Liu, Jinlei Qi, Sha Ran, Shiya Yang, Maigeng Zhou

Abstract

Importance: Cardiovascular disease (CVD) remains the top cause of death in China. To our knowledge, no consistent and comparable assessments of CVD burden have been produced at subnational levels, and little is understood about the spatial patterns and temporal trends of CVD in China.

Objective: To determine the national and province-level burden of CVD from 1990 to 2016 in China.

Design, setting, and participants: Following the methodology framework and analytical strategies used in the 2016 Global Burden of Disease study, the mortality, prevalence, and disability-adjusted life-years (DALYs) of CVD in the Chinese population were examined by age, sex, and year and according to 10 subcategories. Estimates were produced for all province-level administrative units of mainland China, Hong Kong, and Macao.

Exposures: Residence in China.

Main outcomes and measures: Mortality, prevalence, and DALYs of CVD.

Results: The annual number of deaths owing to CVD increased from 2.51 million to 3.97 million between 1990 and 2016; the age-standardized mortality rate fell by 28.7%, from 431.6 per 100 000 persons in 1990 to 307.9 per 100 000 in 2016. Prevalent cases of CVD doubled since 1990, reaching nearly 94 million in 2016. The age-standardized prevalence rate of CVD overall increased significantly from 1990 to 2016 by 14.7%, as did rates for ischemic heart disease (19.1%), ischemic stroke (36.6%), cardiomyopathy and myocarditis (23.1%), and endocarditis (26.7%). Substantial reduction in the CVD burden, as measured by age-standardized DALY rate, was observed from 1990 to 2016 nationally, with a greater reduction in women (43.7%) than men (24.7%). There were marked differences in the spatial patterns of mortality, prevalence, and DALYs of CVD overall as well as its main subcategories, including ischemic heart disease, hemorrhagic stroke, and ischemic stroke. The CVD burden appeared to be lower in coastal provinces with higher economic development. The between-province gap in relative burden of CVD increased from 1990 to 2016, with faster decline in economically developed provinces.

Conclusions and relevance: Substantial discrepancies in the total CVD burden and burdens of CVD subcategories have persisted between provinces in China despite a relative decrease in the CVD burden. Geographically targeted considerations are needed to tailor future strategies to enhance CVD health throughout China and in specific provinces.

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.. Map of Age-Standardized Percentage Change…
Figure 1.. Map of Age-Standardized Percentage Change in Disability-Adjusted Life-Year Rates for Cardiovascular Disease, Ischemic Heart Disease, Hemorrhagic Stroke, and Ischemic Stroke From 1990 to 2016
Figure 2.. Map of Age-Standardized Disability-Adjusted Life-Year…
Figure 2.. Map of Age-Standardized Disability-Adjusted Life-Year Rates for Cardiovascular Disease (CVD), Ischemic Heart Disease (IHD), Hemorrhagic Stroke (HS), and Ischemic Stroke (IS) in 2016

References

    1. Sacco RL, Roth GA, Reddy KS, et al. . The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation. Circulation. 2016;133(23):e674-e690. doi:10.1161/CIR.0000000000000395
    1. Zhou M, Wang H, Zhu J, et al. . Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251-272. doi:10.1016/S0140-6736(15)00551-6
    1. UN General Assembly Political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. . Accessed August 21, 2018.
    1. United Nations Goal 3: ensure healthy lives and promote well-being for all at all ages. . Accessed August 21, 2018.
    1. The State Council of the People’s Republic of China State Council issues plan to prevent chronic diseases. . Accessed August 21, 2018.
    1. Yang XY, Li XF, Lü XD, Liu YL. Incidence of congenital heart disease in Beijing, China. Chin Med J (Engl). 2009;122(10):1128-1132.
    1. He L, Tang X, Song Y, et al. . Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: a population-based survey of 58,308 residents. BMC Public Health. 2012;12:34. doi:10.1186/1471-2458-12-34
    1. Gong W, Wei X, Liang Y, et al. . Urban and rural differences of acute cardiovascular disease events: a study from the population-based real-time surveillance system in Zhejiang, China in 2012. PLoS One. 2016;11(11):e0165647. doi:10.1371/journal.pone.0165647
    1. Sun XG, Wang YL, Zhang N, et al. . Incidence and trends of stroke and its subtypes in Changsha, China from 2005 to 2011. J Clin Neurosci. 2014;21(3):436-440. doi:10.1016/j.jocn.2013.04.028
    1. Li B, Lou Y, Gu H, et al. . Trends in incidence of stroke and transition of stroke subtypes in rural Tianjin China: a population-based study from 1992 to 2012. PLoS One. 2015;10(10):e0139461. doi:10.1371/journal.pone.0139461
    1. Wang W, Jiang B, Sun H, et al. ; NESS-China Investigators . Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759-771. doi:10.1161/CIRCULATIONAHA.116.025250
    1. Wang W, Hu SS, Kong LZ, et al. ; Editorial Board . Summary of report on cardiovascular diseases in China, 2012. Biomed Environ Sci. 2014;27(7):552-558.
    1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448-457. doi:10.1056/NEJMra1201534
    1. GBD 2016 Mortality Collaborators Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1084-1150. doi:10.1016/S0140-6736(17)31833-0
    1. GBD 2016 Causes of Death Collaborators Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-1210. doi:10.1016/S0140-6736(17)32152-9
    1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259. doi:10.1016/S0140-6736(17)32154-2
    1. GBD 2016 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260-1344. doi:10.1016/S0140-6736(17)32130-X
    1. GBD 2016 Risk Factors Collaborators Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345-1422. doi:10.1016/S0140-6736(17)32366-8
    1. Liu S, Wu X, Lopez AD, et al. . An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016;94(1):46-57. doi:10.2471/BLT.15.153148
    1. Wang Y, Li X, Zhou M, et al. . Under-5 mortality in 2851 Chinese counties, 1996-2012: a subnational assessment of achieving MDG 4 goals in China. Lancet. 2016;387(10015):273-283. doi:10.1016/S0140-6736(15)00554-1
    1. National Health and Family Planning Commission An Analysis Report of National Health Services Survey in China, 2013. Beijing, China: Chinese Union Medical University Press; 2015.
    1. Chinese Center for Disease Control and Prevention China Chronic Disease and Risk Factor Surveillance 2013. Beijing, China: Military Medical Science Press; 2016.
    1. Roth GA, Johnson C, Abajobir A, et al. . Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1-25. doi:10.1016/j.jacc.2017.04.052
    1. Salomon JA, Vos T, Hogan DR, et al. . Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2129-2143. doi:10.1016/S0140-6736(12)61680-8
    1. Haagsma JA, Maertens de Noordhout C, Polinder S, et al. . Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr. 2015;13:10. doi:10.1186/s12963-015-0042-4
    1. Salomon JA, Haagsma JA, Davis A, et al. . Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712-e723. doi:10.1016/S2214-109X(15)00069-8
    1. GBD 2015 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603-1658. doi:10.1016/S0140-6736(16)31460-X
    1. Li Y, Zeng X, Liu J, et al. . Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030? BMC Med. 2017;15(1):132. doi:10.1186/s12916-017-0894-5
    1. World Health Organization Decisions and list of resolutions. . Accessed September 19, 2018.
    1. Wang W, Wang D, Liu H, et al. . Trend of declining stroke mortality in China: reasons and analysis. Stroke Vasc Neurol. 2017;2(3):132-139. doi:10.1136/svn-2017-000098
    1. Wang Z, Hu S, Sang S, Luo L, Yu C. Age-period-cohort analysis of stroke mortality in China: data from the Global Burden of Disease Study 2013. Stroke. 2017;48(2):271-275. doi:10.1161/STROKEAHA.116.015031
    1. Zhang LF, Yang J, Hong Z, et al. ; Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology . Proportion of different subtypes of stroke in China. Stroke. 2003;34(9):2091-2096. doi:10.1161/01.STR.0000087149.42294.8C
    1. Li J, Li X, Wang Q, et al. ; China PEACE Collaborative Group . ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data [published retraction and replacement appears in Lancet. 2015;385(9966):402]. Lancet. 2015;385(9966):441-451. doi:10.1016/S0140-6736(14)60921-1
    1. Du X, Gao R, Turnbull F, et al. ; CPACS Investigators . Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes. 2014;7(2):217-226. doi:10.1161/CIRCOUTCOMES.113.000526
    1. Ranasinghe I, Rong Y, Du X, et al. ; CPACS Investigators . System barriers to the evidence-based care of acute coronary syndrome patients in China: qualitative analysis. Circ Cardiovasc Qual Outcomes. 2014;7(2):209-216. doi:10.1161/CIRCOUTCOMES.113.000527
    1. Zhao D, Liu J, Wang W, et al. . Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke. 2008;39(6):1668-1674. doi:10.1161/STROKEAHA.107.502807
    1. Wang L, Gao P, Zhang M, et al. . Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515-2523. doi:10.1001/jama.2017.7596
    1. Bi Y, Jiang Y, He J, et al. ; 2010 China Noncommunicable Disease Surveillance Group . Status of cardiovascular health in Chinese adults. J Am Coll Cardiol. 2015;65(10):1013-1025. doi:10.1016/j.jacc.2014.12.044
    1. National Center for Cardiovascular Diseases Report on Cardiovascular Diseases in China, 2016. Beijing, China: Encyclopedia of China Publishing House; 2017.
    1. Wei YD, Hu DY, Zhang RF, et al. . Metabolic syndrome complicated by peripheral arterial disease: clinical study of 2115 cases [in Chinese]. Zhonghua Yi Xue Za Zhi. 2006;86(30):2114-2116.
    1. Guocheng L, Liansheng R. Prevalence of peripheral arterial disease and its risk factors in Zhoushan fishery area in Zhejiang Province [in Chinese]. Chin J Geriatr. 2005;24(11):863-865.
    1. Cang Y, Li J, Li YM, et al. . Relationship of a low ankle-brachial index with all-cause mortality and cardiovascular mortality in Chinese patients with metabolic syndrome after a 6-year follow-up: a Chinese prospective cohort study. Intern Med. 2012;51(20):2847-2856. doi:10.2169/internalmedicine.51.7718
    1. Xie W, Liang L, Zhao L, et al. . Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events. Heart. 2011;97(16):1326-1331. doi:10.1136/hrt.2011.223032
    1. Wang J, Li XY, He Y, Ni B. A cross-sectional study of peripheral arterial occlusive disease in Wanshoulu area, Beijing [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25(3):221-224.
    1. Li Y, Wang L, Feng X, et al. . Geographical variations in hypertension prevalence, awareness, treatment and control in China: findings from a nationwide and provincially representative survey. J Hypertens. 2018;36(1):178-187. doi:10.1097/HJH.0000000000001531
    1. Zhou M, Astell-Burt T, Bi Y, et al. . Geographical variation in diabetes prevalence and detection in china: multilevel spatial analysis of 98,058 adults. Diabetes Care. 2015;38(1):72-81. doi:10.2337/dc14-1100
    1. Li Z, Wang C, Zhao X, et al. ; China National Stroke Registries . Substantial progress yet significant opportunity for improvement in stroke care in China. Stroke. 2016;47(11):2843-2849. doi:10.1161/STROKEAHA.116.014143
    1. Bi Y, Gao R, Patel A, et al. ; CPACS Investigators . Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009;157(3):509-516.e1. doi:10.1016/j.ahj.2008.09.026
    1. Chinese Center for Disease Control and Prevention Report on Chronic Disease Risk Factor Surveillance in China, 2007. Beijing, China: People’s Medical Publishing House; 2010.
    1. Chinese Center for Disease Control and Prevention Report on Chronic Disease Risk Factor Surveillance in China, 2010. Beijing, China: Military Medical Science Press; 2012.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe